Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;35(5):e21442.
doi: 10.1096/fj.202002611R.

Multimodal treatment combining cold atmospheric plasma and acidic fibroblast growth factor for multi-tissue regeneration

Affiliations

Multimodal treatment combining cold atmospheric plasma and acidic fibroblast growth factor for multi-tissue regeneration

Fei Tan et al. FASEB J. 2021 May.

Abstract

Cold atmospheric plasma (CAP) is an emerging technology for biomedical applications, exemplified by its antimicrobial and antineoplastic potentials. On the contrary, acidic fibroblast growth factor (aFGF) has been a long-standing potent mitogen for cells from various origins. In this study, we are the first to develop a multimodal treatment combining the aforementioned physicochemical and pharmacological treatments and investigated their individual and combined effects on wound healing, angiogenesis, neurogenesis, and osteogenesis. This work was performed at the tissue, cellular, protein, and gene levels, using histochemical staining, flow cytometry, ELISA, and PCR, respectively. Depending on the type of target tissue, various combinations of aforementioned methods were used. The results showed that the enhancement on would healing and angiogenesis by CAP and aFGF were synergistic. The former was manifested by increased murine fibroblast proliferation and reduced cutaneous tissue inflammation, whereas the latter by upregulated proangiogenic markers in vivo, for example, CD31, VEGF, and TGF-β, and downregulated antiangiogenic proteins in vitro, for example, angiostatin and angiopoietin-2, respectively. In addition, aFGF outperformed CAP during neurogenesis, which was evidenced by superior neurite outgrowth, while CAP exceeded aFGF in osteogenesis which was demonstrated by more substantial bone nodule formation. These novel findings not only support the fact that CAP and aFGF are both multipotent agents during tissue regeneration, but also highlight the potential of our multimodal treatment combining the individual advantages of CAP and aFGF. The versatile administration route, that is, topical and/or systemic, might further broaden its applications.

Keywords: EA.hy926; FGF; L-929; PC-12; Saos-2; angiogenesis; atmospheric plasma; cell attachment; cell differentiation; cell migration; cell proliferation; cold plasma; neurite; neurogenesis; nonthermal plasma; osteogenesis; plasma medicine; plasma-activated medium; wound healing.

PubMed Disclaimer

References

REFERENCES

    1. Samukawa S, Hori M, Rauf S, et al. The 2012 plasma roadmap. J Phys D Appl Phys. 2012;45:253001.
    1. Tan F, O'Neill F, Naciri M, Dowling D, Al-Rubeai M. Cellular and transcriptomic analysis of human mesenchymal stem cell response to plasma-activated hydroxyapatite coating. Acta Biomater. 2012;8:1627-1638.
    1. Tan F, Al-Rubeai M. Customizable implant-specific and tissue-specific extracellular matrix protein coatings fabricated using atmospheric plasma. Front Bioeng Biotechnol. 2019;7:247.
    1. Tan F, Al-Rubeai M. A multifunctional dexamethasone-delivery implant fabricated using atmospheric plasma and its effects on apoptosis, osteogenesis and inflammation. Drug Deliv Transl Res. 2020;11(1):86-102.
    1. Bekeschus S, Schmidt A, Weltmann KD, von Woedtke T. The plasma jet kINPen - a powerful tool for wound healing. Clin Plasma Med. 2016;4:19-28.

Publication types

LinkOut - more resources